John L. Andrews

2.5k citations

19 papers · 730 indexed · h-index 14

Co-authors: Diane M. Ignar Aaron S. Goetz Celia P. Briscoe David F. Corbett Andrew J. Peat Terry Kenakin James A. Fornwald Carina Ämmälä
Topics: Protease and Inhibitor Mechanisms (6 papers)Monoclonal and Polyclonal Antibodies Research (6 papers)Glycosylation and Glycoproteins Research (3 papers)
Cited by: Endocrinology, Diabetes and Metabolism Molecular Biology Endocrine and Autonomic Systems
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Analytical Chemistry
Partner nations: United States Australia United Kingdom

In The Last Decade

John L. Andrews

19 papers receiving 706 citations

Peers

Countries citing papers authored by John L. Andrews

Since Specialization

Citations

This map shows the geographic impact of John L. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John L. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John L. Andrews more than expected).

Fields of papers citing papers by John L. Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John L. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John L. Andrews. The network helps show where John L. Andrews may publish in the future.

Co-authorship network of co-authors of John L. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of John L. Andrews. A scholar is included among the top collaborators of John L. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John L. Andrews. John L. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	In vitro evolution of antibody affinity via insertional scanning mutagenesis of an entire antibody variable region 2020 ·Proceedings of the National Academy of Sciences ·(unknown),Stéphane Emond,Matthieu Chodorge,John L. Andrews,D. Gareth Rees,(unknown),Bojana Popovic,Andrew Buchanan,Ralph Minter,Florian Hollfelder	15
2	Rate of Asparagine Deamidation in a Monoclonal Antibody Correlating with Hydrogen Exchange Rate at Adjacent Downstream Residues 2017 ·Analytical Chemistry ·Jonathan J. Phillips,Andrew Buchanan,John L. Andrews,Matthieu Chodorge,Sudharsan Sridharan,L. Mitchell,(unknown),Alistair D. Kippen,Tristan J. Vaughan,Daniel R. Higazi,David C. Lowe	32
3	Expression of high-affinity human antibody fragments in bacteria 2012 ·Nature Protocols ·Romain Rouet,David C. Lowe,Kip Dudgeon,Brendan Roome,Peter R. Schofield,David B. Langley,John L. Andrews,Peter L Whitfeld,Lutz Jermutus,Daniel Christ	58
4	Feasibility of Implementing Cell-Based Pathway Reporter Assays in Early High-Throughput Screening Assay Cascades for Antibody Drug Discovery 2012 ·SLAS DISCOVERY ·Alison J. Smith,Michael K. Hancock,Kun Bi,John L. Andrews,(unknown),Tristan J. Vaughan	9
5	A concise synthesis of 1,4-dihydro-[1,4]diazepine-5,7-dione, a novel 7-TM receptor ligand core structure with melanocortin receptor agonist activity 2010 ·Bioorganic & Medicinal Chemistry ·Jerzy R. Szewczyk,Christopher P. Laudeman,(unknown),(unknown),Douglas J. Minick,Mary K. Grizzle,Alejandro J. Daniels,John L. Andrews,Diane M. Ignar	3
6	Preclinical evaluation of 213Bi-labeled plasminogen activator inhibitor type 2 in an orthotopic murine xenogenic model of human breast carcinoma 2007 ·Molecular Cancer Therapeutics ·(unknown),Fares Al‐Ejeh,(unknown),David R. Croucher,John L. Andrews,David O. Irving,Matthew Links,Marie Ranson	25
7	Pharmacological regulation of insulin secretion in MIN6 cells through the fatty acid receptor GPR40: identification of agonist and antagonist small molecules 2006 ·British Journal of Pharmacology ·Celia P. Briscoe,Andrew J. Peat,Stephen C. McKeown,David F. Corbett,Aaron S. Goetz,(unknown),(unknown),Terry Kenakin,John L. Andrews,Carina Ämmälä,James A. Fornwald,Diane M. Ignar,Stephen Jenkinson	343
8	A Potent Human Anti-Eotaxin1 Antibody, CAT-213: Isolation by Phage Display and in Vitro and in Vivo Efficacy 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Sarah Main,Rachel Handy,Jane Wilton,Stephen Smith,(unknown),(unknown),John L. Andrews,(unknown),Richard May,Ian Anderson,Tristan J. Vaughan	20
9	Regulation of TNF-α secretion by a specific melanocortin-1 receptor peptide agonist 2003 ·Peptides ·Diane M. Ignar,John L. Andrews,Marilyn Jansen,(unknown),(unknown),Peiyuan Lin,Ronald G. Sherrill,Jerzy R. Szewczyk,James G. Conway	24
10	Crystal Structure of the Complex of Plasminogen Activator Inhibitor 2 with a Peptide Mimicking the Reactive Center Loop 2001 ·Journal of Biological Chemistry ·Lucy Jankova,S.J. Harrop,Darren N. Saunders,John L. Andrews,(unknown),(unknown),Mark S. Baker,Paul M. G. Curmi	22
11	Development of a Facile Method for High Throughput Screening with Reporter Gene Assays 2000 ·SLAS DISCOVERY ·Aaron S. Goetz,John L. Andrews,(unknown),Diane M. Ignar	19
12	Development of Class-Switched, Affinity-Matured Monoclonal Antibodies Following a 7-Day Immunization Schedule 1999 ·Hybridoma ·Jane M. Bynum,John L. Andrews,BYRON ELLIS,Frederick C. Kull,Elizabeth A. Austin,(unknown)	11
13	Inhibition of establishment of primary and micrometastatic tumors by a urokinase plasminogen activator receptor antagonist 1998 ·Clinical & Experimental Metastasis ·Diane M. Ignar,John L. Andrews,(unknown),(unknown),William C. Clay,Katherine E. Kilpatrick,James A. Onori,Thomas A. Kost,David L. Emerson	29
14	Production of a urokinase plasminogen activator-IgG fusion protein (uPA-IgG) in the baculovirus expression system 1997 ·Gene ·Thomas A. Kost,Diane M. Ignar,William C. Clay,John L. Andrews,(unknown),Laurie K. Overton,Christine R. Hoffman,Katherine E. Kilpatrick,Byron Ellis,David L. Emerson	8
15	Kinetic properties of HIV-1 protease produced by total chemical synthesis with cysteine residues replaced by isosteric L-?-amino-n-butyric acid 1995 ·Letters in Peptide Science ·Douglas A. Bergman,Dianne Alewood,Paul F. Alewood,John L. Andrews,Ross I. Brinkworth,(unknown),Stephen B. H. Kent	11
16	An ¹H NMR determination of the three‐dimensional structures of mirror‐image forms of a Leu‐5 variant of the trypsin inhibitor from Ecballium elaterium (EETI‐II) 1994 ·Protein Science ·Katherine J. Nielsen,Dianne Alewood,John L. Andrews,Stephen B. H. Kent,David J. Craik	33
17	The serine proteinase inhibitory proteins of the human intervertebral disc: Their isolation, characterization and variation with ageing and degeneration 1992 ·Matrix ·James Melrose,Peter Ghosh,T.K.F. Taylor,John L. Andrews	17
18	Low molecular weight serine proteinase inhibitors of human articular cartilage. Isolation, Characterization, and Biosynthesis 1990 ·Arthritis & Rheumatism ·John L. Andrews,Peter Ghosh	16
19	Ammonium 4-chloro-7-sulfobenzofurazan: A new fluorigenic thiol-specific reagent 1982 ·Archives of Biochemistry and Biophysics ·John L. Andrews,Peter Ghosh,B. Ternai,M. W. Whitehouse	35

About John L. Andrews

John L. Andrews is a scholar working on Cancer Research, Immunology and Allergy and Nutrition and Dietetics, having authored 19 papers that have together received 730 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (141 citations), Molecular Biology (449 citations) and Endocrine and Autonomic Systems (42 citations). John L. Andrews has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Diane M. Ignar, Aaron S. Goetz, Celia P. Briscoe, David F. Corbett, Andrew J. Peat, Terry Kenakin, James A. Fornwald, Carina Ämmälä, Stephen Jenkinson and Stephen C. McKeown. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact